* The primary trend of the stock is bullish, although prices witnessed a bearish retracement for over a year (Sep 2024 - Oct 2025)
* Since strong Q3 earnings (Oct 2025), a bullish pull-back could be seen, and prices rose more than 16.5% in over +3 months
* Recently prices tested fib level 0.618 (86.67) and started consolidating between fib level 0.618 & 0.50.
* Today's strong earnings results of the company for Q4 might drive the stock prices higher.
* The stock is expected to open with a gap-up near the Entry zone, and rise higher towards the Target area
Technical Indicators
- The prices are existing at the support of the 21 EMA
- A hidden bullish divergence is also visible, driving prices higher
Q4 & Annual Earnings
- Colgate-Palmolive beat estimated earnings by 4.0%, reporting an EPS of $0.95 versus an estimate of $0.91.
- Revenue was up $286.00 million from the same period last year.
- EPS, although beat estimates, but fell 106% from the previous quarter, and turned negative for the quarter
- EPS for the financial year also fell 25% to $2.63 from $3.51
* Since strong Q3 earnings (Oct 2025), a bullish pull-back could be seen, and prices rose more than 16.5% in over +3 months
* Recently prices tested fib level 0.618 (86.67) and started consolidating between fib level 0.618 & 0.50.
* Today's strong earnings results of the company for Q4 might drive the stock prices higher.
* The stock is expected to open with a gap-up near the Entry zone, and rise higher towards the Target area
Technical Indicators
- The prices are existing at the support of the 21 EMA
- A hidden bullish divergence is also visible, driving prices higher
Q4 & Annual Earnings
- Colgate-Palmolive beat estimated earnings by 4.0%, reporting an EPS of $0.95 versus an estimate of $0.91.
- Revenue was up $286.00 million from the same period last year.
- EPS, although beat estimates, but fell 106% from the previous quarter, and turned negative for the quarter
- EPS for the financial year also fell 25% to $2.63 from $3.51
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.